Diseases /

Cervical Adenocarcinoma

Back to Diseases List
Associated Genetic Biomarkers

Overview

NCI Definition: An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type. [1]

Clinical Trials

View Clinical Trials for Cervical Adenocarcinoma

Disease Details

Synonyms
Adenocarcinoma of Cervix Uteri, Cervix Uteri Adenocarcinoma, Adenocarcinoma of Uterine Cervix, Adenocarcinoma of the Uterine Cervix, Adenocarcinoma of the Cervix, Uterine Cervix Adenocarcinoma, Adenocarcinoma - cervix, Adenocarcinoma of the Cervix Uteri, Cervix Adenocarcinoma, Adenocarcinoma of Cervix
Parent(s)
Cervical Carcinoma
Children
Cervical Adenocarcinoma In Situ, Early Invasive Cervical Adenocarcinoma, Cervical Serous Adenocarcinoma, Cervical Clear Cell Adenocarcinoma, Cervical Mesonephric Adenocarcinoma, Cervical Villoglandular Adenocarcinoma, Cervical Endometrioid Adenocarcinoma, and Cervical Mucinous Adenocarcinoma
OncoTree Name
Cervical Adenocarcinoma
OncoTree Code
CEAD

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.